Assessment of the genotoxic and cytotoxic potential of an anti-epileptic drug, phenobarbital, in mice: A time course study

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 563, Issue 1, 2004, Pages 1-11

  Biswas, Surjyo Jyoti ^a   Pathak, Surajit ^a   Khuda Bukhsh, Anisur Rahman ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

Cytotoxicity; Genotoxicity; Marker enzymes; Phenobarbital; SDS PAGE; Spermatotoxicity

Indexed keywords

ANTICONVULSIVE AGENT; BIOLOGICAL MARKER; LIVER PROTEIN; PHENOBARBITAL;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ASSAY; GENOTOXICITY; LIVER FUNCTION; LONG TERM CARE; MICRONUCLEUS; MITOSIS INDEX; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SPERMATOZOON; SPERMATOZOON ABNORMALITY; STANDARD; TECHNIQUE; TESTIS; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HUMAN; KIDNEY; LIVER; MALE; METABOLISM; MUTAGEN TESTING; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGY; SPLEEN; TIME;

MAMMALIA;

ADMINISTRATION, ORAL; ANIMALS; ANTICONVULSANTS; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; HUMANS; KIDNEY; LIVER; MALE; MICE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MITOTIC INDEX; MUTAGENICITY TESTS; PHENOBARBITAL; SPERM HEAD; SPLEEN; TIME FACTORS;

EID: 8644283540     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2004.05.016     Document Type: Article

References (46)

1. Aydinlik H., Nguyen T.D., Moennikes O., Buchmann A., Schwarz M. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene. 20(53):2001;7812-7816
2. Kitagawa T., Sugano H. Enhancement of azo-dye induced hepatocarcinogenesis with dietary phenobarbital in rats. Gann. 68:1977;255-256
3. International Agency for Research on Cancer (IARC) - Summaries and Evaluations, Phenobarbital and its Sodium Salt, Group 2B, vol. 79, 2001, pp. 161-162.
4. Maekawa A., Onodera H., Ogasawara H., Matsushima Y., Mitsomuri K., Hayashi Y. Threshold dose-dependence in phenobarbital promotion of rat hepatocarcinogenesis initiated by diethylnitrosamine. Carcinogenesis. 13:1992;501-503
5. Pitot H.C., Goldsworthy T.L., Moran S., Kennan W., Glauert H.P., Maronpot R.R., Campbell H.A. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis. 8:1987;1491-1499
6. Kitagawa T., Hino O., Nomura K., Sugano H. Dose-response studies on promoting and anticarcinogenic effects of phenobarbital and DDT in the rat hepatocarcinogenesis. Carcinogenesis. 5:1984;1653-1656
7. Lee G.H. Paradoxical effects of phenobarbital on mouse carcinogenesis. Toxicol. Pathol. 28:2000;215-225
8. Kinoshita A., Wanibuchi H., Wei K.M., Shen J., Imaoka S., Funae Y., Fukushima S. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression. Carcinogenesis. 24(8):2003;1399-1399
9. Dikranian K., Olney J.W., Ikonomidou C. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc. Natl. Acad. Sci. U.S.A. 99(23):2002;15089-15092
10. Hong S.K., Anestis D.K., Valentovic M.A., Ball J.G., Brown P.I., Rankin G.O. Gender differences in the potentiation of N- (3,5-dichlorophenyl) succinimide metabolite nephrotoxicity by phenobarbital. J. Toxicol. Environ. Health. 64(3):2001;241-256
11. Peraino C., Fry R.J.M., Staffeldt E.F. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2- acetylaminofluorene. Cancer Res. 31:1971;1506-1512
12. Feldman D., Swarm R.L., Becker J. Ultrastructural study of rat liver and liver neoplasms after long-term treatment with phenobarbital. Cancer Res. 41:1981;2151-2162
13. Manjeshwar S., Laconi E., Sheikh A., Rao P.M., Rajalakshmi S., Sarma D.S. In vitro and in vivo response of hepatocytes from hepatic nodules to the mitoinhibitory effects of phenobarbital. Carcinogenesis. 15:1994;1963-1968
14. Kato R., Loeb L., Gelboin B. Microsome specific stimulation by phenobarbital in aminoacid incorporation in vivo. Biochem. Pharmacol. 14:1965;1164-1168
15. Khuda Bukhsh A.R., Chakrabarti J., Mallick P., Khuda Bukhsh A., Mohanty K.C., Biswas S.J. Cytogenetic effects of sonication on Spathosternum prasiniferum (Grasshopper), Anabas testudineus (Fish), and Mus musculus (Mammal). Bull. Environ. Contam. Toxicol. 66:2001;118-124
16. W. Schmid, Principles and Methods of Detection, in: A.E. Hollaender (Ed.), Chemical Mutagens, Plenum Press, New York, 1976.
17. A.J. Wyrobek, G. Watchmaker, L. Gordon, Sperm morphology testing in mice, in: B.J. Kilbey, M. Legator, W. Nichols, C. Ramel (Eds.), Handbook of Mutagenecity Test Procedures, Elsevier Science, Amsterdam, 1984, pp. 733-750.
18. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin-Phenol reagent. J. Biol. Chem. 193:1951;265-275
19. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 105:1984;302-310
20. H.U. Bergmeyer, E. Brent, Methods of enzymatic analysis, in: H.U. Bergmeyer (Ed.), Verlag Chemie Weinhein, vol. 2, Academic Press, New York, 1974, p. 735, 760.
21. K. Walter, C. Schutt, Acid and alkaline phosphatases in serum (Two point method), in: H.U. Bergmeyer (Ed.), Methods in Enzymatic Analysis, vol. 2, Academic Press, New York, USA, 1974, pp. 856-860.
22. 4. Nature. 227:1970;680-685
23. R.A. Fisher, F. Yates, Statistical Tables for Biological, Agricultural and Medical Research, sixth ed., Oliver and Boyd, Edinburgh, 1963.
24. Dessens A.B., Cohen-Kettenis P.T., Mellenbergh G.J., Koppe J.G., Poll N.E.V.D., Boer K. Association of pre-natal phenobarbital and phenytoin exposure with genital anomalies and menstrual disorders. Teratology. 64:2001;181-188
25. Lindhout D., Meimardi H., Meijer J. Anti-epileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology. 42(Suppl. 5):1992;94-110
26. G. Smith, L.A. Stanley, E. Sim, Metabolic Polymorphism's and Cancer Susceptibility, Cancer Surveys, Genetics and Cancer: a Second Look, 25 Imperial Cancer Research Fund, 1995.
27. Kaliste-Korhonen K., Tuovinen K., Hanninen O. Effect of phenobarbital and B-naphtholfavone on activities of different rat esterases after paraoxon exposure. Gen. Pharmac. 31:1998;307-312
28. Atesshahin A., Karahanm I., Pirincci I. Effects of phenobarbital on serum and liver paraoxonase and arylesterase activities in rats. Turk. J. Vet. Anim. Sci. 28:2004;363-367
29. Remmer H., Merker H.J. Enzyminduktion und vermehrung von endoplasmatischem reticulum in der leberzelle wahrend der behadlung mit phenobarbital (luminal). Klin. Woschen. 41:1963;276-284
30. Hightower L.E. Heat shock, stress proteins, chaperones and proteotoxicity. Cell. 66:1991;191-197
31. Klaunig J.E., Xu Y., Isenberg J.S., Bachowski S., Kolaja K.L., Jiang J., Stevenson D.E., Walborg E.F. The role of oxidative stress in chemical carcinogenesis. Environ. Health Perspect. 106:1998;289-295
32. Christensen J., Gonzales A., Cattley R., Goldsworthy T. Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens. Cell Growth Diff. 9:1998;815-825
33. Bursch W., Paffe S., Putz B., Barthel G., Schulte-Hermann R. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis. 11:1990;847-853
34. Bursch W., Oberhammer F., Schulte-Hermann R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol. Sci. 13:1992;245-251
35. Melnick R., Huff J. Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation. Toxicol. Indust. Health. 9:1993;415-438
36. J. Hirtle, S. Meyer, J. Brockenbrough, Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation, In: B. Butterworth, T. Slaga, W. Farland, M. McClain (Eds.), Chemically Induced Cell Proliferation: Implications for Risk Assessment, Wiley-Liss, New York, 1991, pp. 209-216.
37. Kolaja K., Stevensen D., Walborg E., Klaunig J. Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis. 17:1996;947-954
38. Plant N., Horley N., Dickins M., Hasmall S., Elcombe C., Bell D. The coordinate regulation of DNA synthesis and suppression of apoptosis is differentially regulated by the liver growth agents, phenobarbital and methylclofenapate. Carcinogenesis. 19:1998;1521-1527
39. Corkoran G., Fix L., Jones D., Moslen M., Nicotera P., Oberhammer F., Buttyan R. Contemporary issues in toxicology. Apoptosis: molecular control point in toxicity. Toxicol. Appl. Pharmacol. 128:1994;169-181
40. Porter T.D., Coon M.J. Cytochrome P450 multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J. Biol. Chem. 266:1991;13469-13472
41. Waxman D.J., Azaroff L. Phenobarbital induction of cytochrome P450 gene expression. Biochem. J. 28:1992;577-592
42. Sueyoshi T., Kawamoto T., Zelko I. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem. 274:1999;6043-6046
43. Kakizaki S., Yamamoto Y., Ueda A., Moore R., Sueyoshi T., Negishi M. Phenobarbital induction of drug/steroid-metabolizing enzymes and nuclear receptor CAR. Biochem. Biophy. Acta. 1619:2003;239-242
44. Litterst C.L., Mimnaugh E.G., Reagan R.L., Gram T.E. Comparison of in vitro drug metabolism by lung, liver and kidney of several common laboratory species. Drug Metabol. Dispos. 3:1975;259-265
45. Dupuy J., Larrieu G., Braun J.P., Alvinerie M., Galtier P. Differential effects of phenobarbital on the constitutive and inducible expression of P4502B and 3A subfamilies in sheep tissues. Can. J. Physiol. Pharmacol. 79(10):2001;848-853
46. Zweers-Zeilmaker W.M., Batzias J., Maas R.F.M., Horbach G.J. In vitro and in vivo oxidative biotransformation in the West-African dwarf goat (Caprus hircus aegagrus): substrate activities and effects of inducers. Xenobiotica. 26:1996;1131-1141